Kimelman & Baird’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $627K | Sell |
9,240
-7,200
| -44% | -$489K | 0.09% | 67 |
|
|
2019
Q2 | $956K | Buy |
16,440
+200
| +1% | +$11.6K | 0.13% | 59 |
|
|
2019
Q1 | $1.14M | Hold |
16,240
| – | – | 0.16% | 59 |
|
|
2018
Q4 | $1.05M | Sell |
16,240
-1,000
| -6% | -$64.4K | 0.16% | 59 |
|
|
2018
Q3 | $1.21M | Hold |
17,240
| – | – | 0.15% | 59 |
|
|
2018
Q2 | $869K | Buy |
+17,240
| New | +$869K | 0.11% | 67 |
|
|
2017
Q4 | $658K | Sell |
19,240
-1,800
| -9% | -$61.6K | 0.09% | 71 |
|
|
2017
Q3 | $675K | Hold |
21,040
| – | – | 0.1% | 71 |
|
|
2017
Q2 | $685K | Hold |
21,040
| – | – | 0.1% | 72 |
|
|
2017
Q1 | $663K | Buy |
21,040
+1,600
| +8% | +$50.4K | 0.1% | 72 |
|
|
2016
Q4 | $571K | Sell |
19,440
-2,000
| -9% | -$58.7K | 0.1% | 73 |
|
|
2016
Q3 | $620K | Hold |
21,440
| – | – | 0.11% | 71 |
|
|
2016
Q2 | $555K | Sell |
21,440
-500
| -2% | -$12.9K | 0.1% | 71 |
|
|
2016
Q1 | $543K | Buy |
21,940
+500
| +2% | +$12.4K | 0.1% | 74 |
|
|
2015
Q4 | $755K | Buy |
+21,440
| New | +$755K | 0.14% | 72 |
|
|
2015
Q2 | $610K | Sell |
21,940
-9,960
| -31% | -$277K | 0.1% | 81 |
|
|
2015
Q1 | $975K | Hold |
31,900
| – | – | 0.18% | 73 |
|
|
2014
Q4 | $1.02M | Sell |
31,900
-3,900
| -11% | -$125K | 0.18% | 68 |
|
|
2014
Q3 | $1.01M | Sell |
35,800
-2,500
| -7% | -$70.7K | 0.19% | 71 |
|
|
2014
Q2 | $1.05M | Buy |
38,300
+1,400
| +4% | +$38.3K | 0.18% | 71 |
|
|
2014
Q1 | $972K | Buy |
36,900
+2,800
| +8% | +$73.8K | 0.18% | 70 |
|
|
2013
Q4 | $998K | Sell |
34,100
-1,500
| -4% | -$43.9K | 0.19% | 69 |
|
|
2013
Q3 | $1.09M | Buy |
35,600
+1,500
| +4% | +$45.9K | 0.22% | 69 |
|
|
2013
Q2 | $1.08M | Buy |
+34,100
| New | +$1.08M | 0.23% | 69 |
|